locus biosciences
Biotech & Health
New clinical trial data from Locus Biosciences shows promise in CRISPR-Cas3 technology
5:15 am PST • March 8, 2021
Antibiotic resistance is one of the biggest potential threats to global health today. But Locus Biosciences is hoping that their crPhage technology might provide a new solution. Based in North…
Biotech & Health
Up to $818 million deal between J&J and Locus Biosciences points to a new path for CRISPR therapies
2:26 pm PST • January 4, 2019
The up to $818 million deal between Locus Biosciences and Janssen Pharmaceuticals (a division of Johnson & Johnson) that was announced yesterday points toward a new path for CRISPR gene…
Biotech & Health
Move over Cas9, CRISPR-Cas3 might hold the key to solving the antibiotics crisis
1:14 pm PST • December 21, 2016
Researchers at North Carolina-based Locus Biosciences think they have a potential cure for antibiotic resistance using CRISPR’s lesser-known Cas3 enzyme. Most of the interest in CRISPR technology centers around the…
